4.32 USD
↘ 0.16 (3.57%)LIVE (AS OF 03:00 PM EDT)
Prelude Therapeutics Incorporated
PRLDNASDAQ • USD
Market: OPEN
Open?$4.44
High?$4.77
Low?$4.29
Prev. Close?$4.48
Volume?360.2K
Avg. Volume?519.7K
VWAP?$4.48
Rel. Volume?0.69x
Bid / Ask
Bid?$3.78 × 100
Ask?$4.39 × 100
Spread?$0.61
Midpoint?$4.09
Valuation & Ratios
Market Cap?356.8M
Shares Out?79.6M
Float?17.1M
Float %?39.0%
P/E Ratio?N/A
P/B Ratio?5.93
EPS?-$0.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
Themes
Employees
79
Market Cap
356.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-09-25
Address
175 INNOVATION BOULEVARD
WILMINGTON, DE 19805
Phone: (302) 467-1280
WILMINGTON, DE 19805
Phone: (302) 467-1280
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.03Strong
Quick Ratio?2.03Strong
Cash Ratio?0.52Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?5.93FAIR▾
P/S?21.34HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.1CHEAP▾
EV/Sales?20.04HIGH▾
Returns & Efficiency
ROE?-129.3%WEAK▾
ROA?-65.0%WEAK▾
Cash Flow & Enterprise
FCF?$-43776000
Enterprise Value?$335.1M
Fundamentals ratios updated end of day